z-logo
open-access-imgOpen Access
Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo
Author(s) -
Katherine L. Williams,
Wahala M. P. B. Wahala,
Susana Orozco,
Aravinda M. de Silva,
Eva Harris
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/jyt6-yd89
Subject(s) - dengue virus , virology , antibody dependent enhancement , dengue vaccine , dengue fever , in vivo , serotype , antibody , envelope (radar) , virus , medicine , biology , immunology , computer science , microbiology and biotechnology , telecommunications , radar

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom